Introduction
Traditional genome-wide association studies (GWAS) have been successfully applied to identify a large number of genetic markers associated with complex diseases and related continuous traits. However, for most complex diseases and continuous traits, all genetic markers identified so far only explain a small proportion of the heritability in these traits, suggesting that a lot of genetic determinants are still undiscovered. Eichler et al. [1] suggested that gene-environment interaction and rare genetic variants may both account for some of the unexplained heritability.
Statistical methods to detect gene-environment interaction have been well-established in the context of singlemarker tests [2] [3] [4] . To determine if a common genetic variant interacts with an environmental variable, we can either test the interaction effect only or jointly test both genetic main effect and gene-environment interaction effect. By using the first approach, we are usually interested in detecting gene-environment interaction, regardless of the presence of a significant genetic main effect. However, by using the second approach, we are testing if the genetic marker is associated with the trait of interest, allowing for gene-environment interaction. These methods combined with multivariate meta-analysis have led to the discovery of novel common loci associated with fasting insulin levels by incorporating gene × body mass index (BMI) interactions [5] . However, the power of singlemarker tests greatly depends on the minor allele frequency (MAF) of the genetic marker tested. As a result, singlemarker tests have little power in testing gene-environment interaction involving rare genetic variants. On the other hand, rare genetic variants analysis has become a popular research field in genetic association studies, and many statistical methods for rare variants analysis have been proposed [6] [7] [8] [9] [10] [11] [12] . Of these methods, the sequence kernel association test (SKAT) [12] has been shown to be a powerful approach in various scenarios. However, all of these methods focus on the main effect association analysis of rare genetic variants.
Compared with common variant analysis, rare variant analysis often requires a larger sample size to attain comparable power. Compared with main effect analysis, interaction analysis also needs a larger sample size. Thus, little attention has been paid to interaction analysis for rare genetic variants, possibly due to the limited sample size in many cohort studies. Tzeng et al. [13] proposed a gene-trait similarity regression approach (SIMreg) to test gene-environment interaction of rare variants. This approach is flexible in the hypothesis testing, and the main effect test, test of interaction and joint test of main effect and interaction are possible. It is available for continuous and binary traits, although the original reference only includes the development for continuous traits. However, in the joint test, it implicitly assumes that the variance component parameters for genetic main effects and geneenvironment interactions are of the same magnitude under the alternative hypothesis, which may not be true. In a first attempt to specifically consider gene-environment interactions for rare variants, Kazma et al. [14] proposed 3 joint tests: (1) minimum p value, (2) CAST [6] , and (3) SKAT [12] . However, they considered only the scenario where the environmental variable is binary when computing SKAT weights, which limits the applicability of their SKAT approach. They used a single kernel for both genetic main effects and gene-environment interactions, and pointed out that it would be valuable to model genetic main effects and gene-environment interactions separately. Recently, Lin et al. [15] have proposed the gene-environment set association test (GESAT) as an interaction test in a generalized linear model framework. Although GESAT was originally developed for common variants, it can be easily applied to rare variants by incorporating weights, which we name GESAT with weights (GESAT-W). This test is applicable to both binary and continuous traits, but the joint test was not provided.
In this paper, we propose a general approach for testing gene-environment interaction of rare variants, including two interaction tests and a joint test. Our approach is flexible and works for both binary and continuous traits. Genetic main effects and gene-environment interactions are modeled separately, and no assumption is required on the magnitude of variance component parameters for genetic main effects and gene-environment interactions. We evaluate the performance of our methods in simulation studies, and we also illustrate our approaches in testing gene × BMI interaction on fasting glucose and fasting insulin levels, adjusting for age, sex, cohort and 10 principal components [16] , using an unrelated subset of individuals from the Framingham Heart Study (FHS).
Methods

Interaction Test
Fixed Genetic Main Effects Our notation is as follows: assuming a sample size of n , let Y i be the phenotype of individual i (1 ≤ i ≤ n ), and follow an exponential family distribution with E (
) be a row vector of length p , consisting of an intercept and ( p -1) covariates, E i be one of these ( p -1) covariates, centered to have a mean of 0, and G i = ( G i 1 , G i 2 , ..., G iq ) be a row vector of q genetic variants.
Assuming independent observations, we can write the generalized linear mixed model for testing the gene by E i interaction as
where g ( · ) is the link function, W 1 and W 2 are q × q diagonal matrices with elements equal to weights for genetic main effects and gene-environment interaction effects, respectively. β is a vector of fixed-effects parameters for the intercept and ( p -1) covariates, γ 1 is a vector of fixed-effects parameters for genetic main effects, γ 2 is a vector of random effects of gene-environment interaction, assumed to have a mean of 0 and covariance matrix τ 2 I q . The interaction test can be constructed as H 0 : τ 2 = 0 versus
T be the mean vector, X be an n × p covariates matrix with elements X ij (where 1 ≤ i ≤ n and 0 ≤ j ≤ p -1) and X i 0 = 1, G be an n × q genotype matrix with elements G ij (where 1 ≤ i ≤ n and 1 ≤ j ≤ q ), and E = diag { E i } be an n × n matrix. We define the working vector under the null hypothesis y = Xβ [17] . Let ε be Δ( Y -μ ), we can write the model as 2 }, and the test statistic for H 0 : τ 2 = 0 is [12, 18] .
This interaction test is straightforward; however, when the number of genetic variants q is large, we cannot usually get stable estimates of γ 1 , leaving it impractical. Below, we propose an alternative interaction test which treats genetic main effects γ 1 as random effects.
Random Genetic Main Effects
We use the same notations as before, but now assume that γ 1 is a vector of random effects with a mean of 0 and covariance matrix τ 1 I q . Again we define the working vector under the null hypothesis
We can get the maximum likelihood (or restricted maximum likelihood) estimates β R , τ 1 R , ϕ R from the null model, and compute
Under the null hypothesis,
where λ j s are the eigenvalues of the matrix
Joint Test
Kraft et al. [2] suggested simultaneously testing genetic main effect and interaction effect in a joint test. In the context of the generalized linear mixed model (see above), a joint test of main and interaction effects in our context is equivalent to testing the following hypotheses:
Under the null hypothesis, we define the working vector y = Xβ + Δ( Y -μ ) with Var ( y ) = V . Let β J , ϕ J be the maximum likelihood (or restricted maximum likelihood) estimates from the null model g ( μ i ) = X i β , then we can calculate estimates
, the hypotheses for the joint test may be rewritten as
where ρ is a nuisance parameter present only under the alternative hypothesis. For any fixed ρ , the test statistic for H 0 : τ = 0 is
Note that if n ≥ q , there are at most q non-zero eigenvalues. When ρ = 1, this is the regular SKAT statistic for genetic main effects. Following Lee et al. [19] , we use the minimum p value as the test statistic:
To compute the p value of observed Q J = q J , following Voorman et al. [20] , we can write the p value as an integral, which needs to be solved numerically. We use a Monte Carlo method in our implementation (see Appendix). There are several ways for computing the p value of the sum of χ 2 s [21] [22] [23] [24] . In this paper, we generally use Kuonen's saddlepoint method [23] (in interaction tests and evaluating F ( x ) in the joint test), except that in the joint test, we use a modified momentmatching method (matching the mean, variance, and kurtosis) [19, 24] to compute p ( ρ S ) and quantiles T ( ρ S ), because it takes much longer to find quantiles using Kuonen's saddlepoint method.
Simulation Studies
We performed simulation studies to evaluate the empirical type I error and power of main effect SKAT [12] , the interaction test treating genetic main effects as fixed (INT-FIX), the interaction test treating genetic main effects as random (INT-RAN), the joint test of genetic main effects and gene-environment interactions (JOINT), SIMreg tests by Tzeng et al. [13] (http://www4.stat. ncsu.edu/ ∼ jytzeng/software_simreg.php), and GESAT-W by Lin et al. [15] . In a preliminary simulation study for continuous traits, it took up to 26 min to get the p value from 1 SIMreg interaction test on 2,000 individuals and 20 genetic variants. As it would not be feasible to run 1,000,000 simulations to evaluate the type I error, we excluded the SIMreg interaction test from the comparison. We also excluded GESAT-W for binary traits as the current package is only available for continuous traits. [12] , which are the beta density function with parameters 1 and 25, evaluated at the MAF of the genetic variant, for SKAT, INT-FIX, INT-RAN, GESAT-W and JOINT. In the joint test, we used the Monte Carlo method with B = 10,000 to calculate the p value. In the SIMreg main effect test (SR) and joint test (SR-JOINT), we used inverse allele frequency as the weight to calculate the genotype similarity matrix, as recommended by Tzeng et al. [13] .
Type I Error We simulated both continuous and binary phenotypes. For continuous traits, we simulated 5,000 genotype datasets with a sample size of 2,000. In each genotype dataset, we simulated 20 biallelic genetic variants with a MAF randomly sampled from a uniform distribution on the interval (0.005, 0.05), and we fixed the linkage disequilibrium correlation between adjacent markers at r = 0.5. For each genotype dataset, we simulated 200 replicates of covariates:
2 ), then we generated the continuous phenotypes Y from For binary traits, we simulated case-control studies with 1,000 cases and 1,000 controls for each replicate. We first simulated 5,000 genotype datasets with a sample size of 20,000. For each genotype dataset, we simulated 200 replicates of covariates. The genetic variants and covariates were simulated following the same procedure as for continuous traits. For each individual, we calculated the probability of disease P ( Y = 1) from For binary traits, we first simulated 5 genotype datasets with a sample size of 20,000, and 200 replicates of covariates for each genotype dataset. The genetic variants and covariates were simulated following the same procedure as in the type I error simulations. For each replicate, we randomly selected 10 causal variants, and we calculated the probability of disease P ( Y = 1) from Table 1 
Results
Type I Error Simulations
includes the empirical type I errors of the 7 tests: (1) genetic main effect test (SKAT); (2) SIMreg main effect test (SR); (3) gene-BMI interaction test adjusting for fixed genetic main effects (INT-FIX); (4) gene-BMI interaction test adjusting for random genetic main effects (INT-RAN); (5) GESAT-W gene-BMI interaction test (GESAT-W); (6) the joint test of genetic main effects and gene-BMI interaction (JOINT)
, and (7) SIMreg joint test (SR-JOINT) at α levels of 0.05, 0.01, 0.001, and 0.0001 from 1,000,000 simulation replicates. For binary traits, GESAT-W is not available yet.
INT-FIX has slightly inflated type I errors at high α levels, and it is more pronounced for binary traits. SR-JOINT is conservative for binary traits. All other tests have empirical type I errors close to the corresponding α levels at all 4 levels we studied. For binary traits, SKAT, INT-RAN, and JOINT are slightly conservative at low α levels, but not as conservative as SR-JOINT. The results suggest that INT-RAN and JOINT, which we propose in this paper, are valid tests. For binary traits, the empirical power results at an α level of 0.0001 from 1,000 simulation replicates are shown in figure 2 . The results have similar patterns as for continuous traits. Generally, the main effect tests are most powerful when the association is dominated by genetic main effects, the interaction tests are most powerful when there are no or weak main effects. The joint tests are most powerful when both main effects and interaction effects are of the same magnitude, and they are only slightly less powerful than the most powerful tests in all other scenarios.
Power Simulations
Computational Time
Although our simulation studies show that SR-JOINT has comparable power to the JOINT test proposed in this paper, a great advantage of our approach is its computational efficiency. We calculated the average computational time for JOINT and SR-JOINT in our type I error simulation settings with sample sizes from 1,000 to 10,000. Table 2 shows that the computational time for SR-JOINT increases almost cubically with the sample size. In contrast, our JOINT test is much faster than SR-JOINT when the sample size is ≥ 2,000. The comparison suggests that in real applications, SR-JOINT may only be applicable to small studies.
We also compared the computational time for the 3 interaction tests: INT-FIX, INT-RAN, and GESAT-W. Table 2 shows that INT-RAN is slower than GESAT-W, while INT-FIX is faster. All 3 interaction tests are much faster than the SIMreg interaction test, which takes up to 26 min for 1 gene with a sample size of 2,000. The interaction tests are also faster than the joint tests.
Application to the FHS
In this real data example, we performed a genomewide sliding window analysis for gene-BMI interaction on fasting glucose and fasting insulin levels. The FHS was initiated in 1948. In 1971, 5,124 individuals who were the (Gen III) . We selected 1,895 unrelated individuals from the FHS Offspring and Gen III Cohorts and analyzed rank-normalized fasting glucose and fasting insulin levels from the most recent physical examination. We adjusted for age, sex, cohort, first 10 principal components, and BMI main effect and tested genetic main effects using SKAT and SR, gene-BMI interaction using INT-FIX, INT-RAN, and GESAT-W, and the joint tests JOINT and SR-JOINT. We used genotype data from the Framingham Single Nucleotide Polymorphism (SNP) Health Association Resource (SHARe) and restricted our analysis to SNPs with a MAF <5%. We defined the gene regions in each test using a sliding window method: each window had a width of 500 kb, with 250 kb each overlapping with the previous and subsequent windows.
We analyzed 11,090 sliding windows from all 22 autosomes. After removing windows with 0 or only 1 rare SNP, we had results from 10,516 windows, with the number of rare SNPs ranging from 2 to 67, with a median of 17. In figure 3 , we present quantile-quantile plots from both analyses, using SKAT, SR, INT-FIX, INT-RAN, GESAT-W, JOINT, and SR-JOINT. There was no systematic inflation of type I errors: most p values were very close to the corresponding expected values. We used 4.75 × 10 -6 as the genome-wide significance level, based on a Bonferroni procedure to control for a family-wise significance level of 0.05. At this significance level, we found only 1 window associated with fasting glucose levels, allowing for gene-BMI interaction. The region is on chromosome 9, with position (NCBI Build 36) between 114,068,775 and 114,568,775, and there are 9 rare SNPs in this region, which are located in genes ROD1 , HSDL2 , KIAA1958 , INIP , SNX30 , and intergenic regions between them. The JOINT test's p value was 2.06 × 10 -6 , but in- We assumed each gene had 20 genetic variants and calculated the mean computational time for each run and standard error of mean (SEM) from 1,000 replicates. The joint tests were slightly less powerful than the main effect tests if there was no interaction, and slightly less powerful than the interaction tests if there was no main effect, which is consistent with our knowledge of the single-marker interaction and joint tests [2] . However, the joint tests were most powerful when both genetic main effect and gene-environment interaction were present, and the power loss compared to the main effect tests or the interaction tests was acceptable when either interaction or main effect was absent or weak, suggesting that the joint tests are an attractive approach for testing genetic association allowing for gene-environment interaction, when we do not have a priori knowledge about the presence of gene-environment interaction.
Tzeng et al. [13, 25] showed that their SIMreg is equivalent to the haplotype random effects model, thus if we replace genotypes by haplotypes in INT-RAN, it is equivalent to the interaction test in gene-trait similarity regression when analyzing continuous traits. Moreover, Tzeng et al.'s joint test would be a special case of our joint test at a fixed ρ = 0.5 if we had analyzed haplotypes. It is not surprising that the gene-trait similarity regression joint test has higher power than our joint test when genetic main effects and interaction effects are of the same magnitude. However, when the sample size is moderate to large, Tzeng et al.'s joint test takes on average 11-465 times as much computational time as our joint test in a single-gene run, which limits its application.
The interaction test proposed by Lin et al. [15] introduces a tuning parameter in the estimation of genetic main effects. They used generalized cross validation [26] to select the tuning parameter. We note that INT-RAN is equivalent to their test if the tuning parameter is unconstrained to their prespecified upper bound and equal to ϕ R / τ 1 R , estimated from our null generalized linear mixed model, treating genetic main effects as random. Moreover, our simulation study showed that the performance of their test is very similar to that of INT-RAN.
Although there are several genes ( ROD1 , HSDL2 , KIAA1958 , INIP , and SNX30 ) overlapping with the region on chromosome 9 found to be associated with fasting glucose levels in the joint test, none of them has previously been reported to influence fasting glucose levels. Little is known about the role of these genes in metabolism regulation, except that HSDL2 may be involved in the cholesterol-responsive atherosclerosis pathway [27] . However, the genotype data we used in the analysis were from SNP arrays originally designed for GWAS, and most SNPs were common and excluded. For rare variant analysis, it would be ideal if we had sequence data which include more densely distributed rare SNPs. We hope to revisit this example in the future.
Gene-environment interaction has been of great interest in recent years, and gene-environment interaction studies on the whole genome have identified novel association loci for many traits [5, [28] [29] [30] . However, most of these studies so far have been performed as single-marker tests and have not been powerful for detecting geneenvironment interaction of rare variants. The interaction and joint tests for gene-environment interaction of rare variants proposed in this paper were developed based on the SKAT framework [12] , a variance component test for multiple genetic variants, which is powerful regardless of the directions of effects of those variants. Also, the proposed approaches can be viewed as a generalization of existing methods under specific conditions. We believe our general approach, especially the joint test, can be readily used in genetic epidemiological studies to test genetic associations with rare variants, allowing for effect modification by an environmental variable, and also facilitate future discoveries.
